Luxembourg vs Malta: The number of people with susceptibility test result for rifampicin
Luxembourg
21
in 2021
Malta
27
in 2021
Luxembourg rank
132nd
Malta rank
129th
The number of people with susceptibility test result for rifampicin over time
- Luxembourg
- Malta
How they compare
Malta currently reports 27 against 21 in Luxembourg, a difference of 6.
That makes Malta's figure about 1.3 times Luxembourg's.
Across all 5 years both countries report, Malta has been ahead every year.
Luxembourg ranks 132nd and Malta ranks 129th of 155 countries.
Malta has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Luxembourg | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.33 | 29 | 23.67 | Malta |
| 2020s | 19.5 | 30.5 | 11 | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Luxembourg or Malta?
- Malta, at 27 against 21 in Luxembourg as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Luxembourg and Malta?
- 6, with Malta ahead.
- How many years of comparable data are there for Luxembourg and Malta?
- 5 years are reported by both, from 2017 to 2021.
- How do Luxembourg and Malta rank globally for the number of people with susceptibility test result for rifampicin?
- Luxembourg ranks 132nd and Malta ranks 129th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.